Z
Zur Rose Group AG
SIX:ROSE
Zur Rose Group AG
SIX:ROSE
Price:
32.3
CHF
-5.56%
Market Closed
Market Cap:
CHf405m
Relative Value
There is not enough data to reliably calculate the relative value of ROSE.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ROSE
Relative Value
Base Case
Not Available
Multiples Across Competitors
ROSE Competitors Multiples
Zur Rose Group AG Competitors
Zur Rose Group AG Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CH |
Z
|
Zur Rose Group AG
SIX:ROSE
|
374.9m CHF | 0.2 | -2.2 | -6.4 | -3.4 | |
| ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
71.1B ZAR | 1.5 | 23.7 | 11.6 | 16.4 | |
| ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
30B ZAR | 0.8 | 25.4 | 10.3 | 15.6 | |
| US |
|
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
10.4B USD | 0.1 | -1.6 | 3 | 5.1 | |
| BR |
|
Raia Drogasil SA
BOVESPA:RADL3
|
41.2B BRL | 0.9 | 32.3 | 10.2 | 18.2 | |
| JP |
|
Tsuruha Holdings Inc
TSE:3391
|
1T JPY | 0.9 | 28.5 | 12.3 | 18.2 | |
| JP |
|
MatsukiyoCocokara & Co
TSE:3088
|
972.3B JPY | 0.9 | 17.3 | 8.1 | 10.3 | |
| SA |
|
Al Nahdi Medical Company SCJSC
SAU:4164
|
16.8B SAR | 1.7 | 20.7 | 10.4 | 19.2 | |
| CN |
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
29B CNY | 1.2 | 17.6 | 13.8 | 13.8 | |
| JP |
|
Welcia Holdings Co Ltd
TSE:3141
|
657.7B JPY | 0.5 | 34.3 | 9.1 | 15.3 | |
| JP |
S
|
Sugi Holdings Co Ltd
TSE:7649
|
635.2B JPY | 0.6 | 15 | 9.1 | 12.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
